Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (4): 657-660. doi: 10.3969/j.issn.1671-167X.2015.04.022

• Articles • Previous Articles     Next Articles

Clinical characteristics and treatment outcomes of microscopic polyangiitis combined with autoimmune hemolytic anemia

LIU Dan1,2, LI Ru1, LIU Jia-yu2, YAO Hai-hong1,CHEN Qin-ping2, JIA Yuan1△ , SU Yin1   

  1. (1. Department of Rheumatology and Immunology,Peking University People’s Hospital, Beijing 100044, China; 2. Department of Rheumatology and Immunology, Fifth Hospital of Xi’an, Xi’an 710082, China)
  • Online:2015-08-18 Published:2015-08-18
  • Contact: JIA Yuan E-mail:jiayuan1023@sina.com

Abstract:

Objective:To investigate the clinical characteristics, laboratory features, outcome and prognosis of microscopic polyangiitis (MPA) patients with autoimmune hemolytic anemia (AIHA). Methods:In this study, 63 cases diagnosed as MPA from October 2006 to November 2013 in Peking University People’s Hospital were reviewed. The clinical characteristics, outcome and prognosis of MPA patients with AIHA were retrospectively analyzed.Results: There were 12.7% (8/63) MPA patients with AIHA. The patients with AIHA had higher prevalence of fever, fatigue, hematuresis, albuminuria and new-onset hypertension, compared with non-AIHA group(87.5% vs.29.1%;100% vs. 49.1%; 100% vs. 60%; 75% vs. 20%, all P<0.05). In patients with AIHA, there were significantly lower levels of red blood cell(RBC), hemoglobin(Hb), alanine albumin(Alb) and complement C3[(2.3±0.5 )×1012/L vs.(3.0±0.7)×1012/L;(66.2±13.1)g/L vs.(90.0±20.3) g/L; (26.1±4.4) g/L vs.(33.5±6.4) g/L; (0.7±0.2) g/L vs.(0.9±0.3)g/L,all P<0.05]. However, the levels of erythrocyte sedimentation rate (ESR), IgG and Birmingham Vasculitis Activity Score (BVAS) were higher, compared with those in the patients without AIHA [(102.1±25.7) mm/1h vs.(76.5±31.1) mm/1h; (20.9±6.1) g/L vs.(14.5±6.0) g/L; ( 23.7 ±5.7)vs.(17.3 ± 4.1), all P<0.05]. The study suggested that there were more severe multi-system damage in the patients with AIHA than in those without AIHA. In the MPA patients with AIHA, six cases received treatment of methylprednisolone combined with immunosuppressant, and two received treatment of methylprednisolone only. Among the eight cases, three were recovered from anemia and four improved. One died of severe lung infection. After 4 years follow-up,in the seven MPA patients with AIHA, three received remission, two died,and two suffered from anemia and abnormal renal function. Conclusion: MPA with AIHA is more complicated by multi-system damage and not rare in clinical settings. Glucocorticoid combined with immunosuppressant is beneficial to induce remission for MPA patients with AIHA.

Key words: Microscopic polyangiitis, Anemia, hemolytic, autoimmune, Signs and symptoms

CLC Number: 

  • R593.2
[1] Xing-yun ZHU,Yan-ying LIU,Xue-juan SUN,Ping YU,Shuang LIU,Mei-yan FU,Xu LIU,Li-min REN,Zhan-guo LI. A cross-sectional study of the clinical features and physician visit patterns at onset of immunoglobulin G4 related disease [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1039-1043.
[2] ZHU Yi-Dan, WEI Jian-Rong, HUANG Lu, WANG Shao-Hua, TIAN Han-Mei, GUO Xin-Biao. Comparison of respiratory diseases and symptoms among school-age children in areas with different levels of air pollution in Beijing [J]. Journal of Peking University(Health Sciences), 2015, 47(3): 395-399.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .